Veronica Gil

2.0k total citations
14 papers, 155 citations indexed

About

Veronica Gil is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Veronica Gil has authored 14 papers receiving a total of 155 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Veronica Gil's work include Histone Deacetylase Inhibitors Research (5 papers), Prostate Cancer Treatment and Research (4 papers) and Acute Myeloid Leukemia Research (3 papers). Veronica Gil is often cited by papers focused on Histone Deacetylase Inhibitors Research (5 papers), Prostate Cancer Treatment and Research (4 papers) and Acute Myeloid Leukemia Research (3 papers). Veronica Gil collaborates with scholars based in United Kingdom, United States and Germany. Veronica Gil's co-authors include Kevin Petrie, Arthur Zelent, Sven Stengel, Yordan Sbirkov, Govind Bhagat, Louise Howell, Chong Kim, Jing Zhang, Lydia Pleotis Howell and Francisco Vega and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Veronica Gil

13 papers receiving 153 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Veronica Gil United Kingdom	8	108	45	29	26	16	14	155
Marni B. McClure Japan	5	67 0.6×	41 0.9×	29 1.0×	41 1.6×	11 0.7×	7	123
Mariko Tabata Japan	5	77 0.7×	47 1.0×	44 1.5×	49 1.9×	9 0.6×	12	148
Roberto Ciaccio Italy	3	184 1.7×	53 1.2×	22 0.8×	48 1.8×	7 0.4×	4	229
Ji-Rong Sun United States	6	82 0.8×	61 1.4×	25 0.9×	21 0.8×	10 0.6×	8	130
Omar Saavedra Spain	9	86 0.8×	66 1.5×	16 0.6×	14 0.5×	10 0.6×	22	167
Tressa Hood United States	8	37 0.3×	71 1.6×	32 1.1×	43 1.7×	11 0.7×	20	133
Nandita Barnabas United States	5	60 0.6×	49 1.1×	36 1.2×	39 1.5×	16 1.0×	6	119
E. L. Woodward Sweden	8	113 1.0×	50 1.1×	20 0.7×	33 1.3×	35 2.2×	14	225
Alyssa Parker United States	6	65 0.6×	28 0.6×	15 0.5×	49 1.9×	8 0.5×	9	111
Valeria Catena Italy	8	162 1.5×	42 0.9×	11 0.4×	45 1.7×	7 0.4×	10	203

Countries citing papers authored by Veronica Gil

Since Specialization

Citations

This map shows the geographic impact of Veronica Gil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veronica Gil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veronica Gil more than expected).

Fields of papers citing papers by Veronica Gil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veronica Gil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veronica Gil. The network helps show where Veronica Gil may publish in the future.

Co-authorship network of co-authors of Veronica Gil

This figure shows the co-authorship network connecting the top 25 collaborators of Veronica Gil. A scholar is included among the top collaborators of Veronica Gil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veronica Gil. Veronica Gil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Zammarchi, Francesca, Karin Havenith, Veronica Gil, et al.. (2023). Abstract 2638: Preclinical development of ADCT-212, a PSMA-targeted antibody-drug conjugate employing the pyrrolobenzodiazepine dimer SG2000 for PSMA-expressing cancers. Cancer Research. 83(7_Supplement). 2638–2638. 2 indexed citations

Sheehan, Beshara, Antje Neeb, Lorenzo Buroni, et al.. (2022). Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer. Clinical Cancer Research. 28(14). 3104–3115. 22 indexed citations

Stengel, Sven, Kevin Petrie, Yordan Sbirkov, et al.. (2022). Suppression of MYC by PI3K/AKT/mTOR pathway inhibition in combination with all‐trans retinoic acid treatment for therapeutic gain in acute myeloid leukaemia. British Journal of Haematology. 198(2). 338–348. 17 indexed citations

Gil, Veronica, Christina Guo, George Seed, et al.. (2022). Abstract 2898: HPN424, a Tri-specific T-cell Activating Construct, induces T cell-mediated cytotoxicity against human metastatic castration-resistant prostate cancers (mCRPC). Cancer Research. 82(12_Supplement). 2898–2898.

Kolinsky, Michael, Nikolas H. Stoecklein, Maryou B. Lambros, et al.. (2019). Genetic Analysis of Circulating Tumour Cells. Recent results in cancer research. 215. 57–76. 11 indexed citations

Rescigno, Pasquale, Gunther Boysen, Daniel Nava Rodrigues, et al.. (2018). Molecular and clinical implications of CHD1 loss and SPOP mutations in advanced prostate cancer.. Journal of Clinical Oncology. 36(15_suppl). 5064–5064. 1 indexed citations

Sbirkov, Yordan, Colin Kwok, Amandeep Bhamra, et al.. (2017). Semi-Quantitative Mass Spectrometry in AML Cells Identifies New Non-Genomic Targets of the EZH2 Methyltransferase. International Journal of Molecular Sciences. 18(7). 1440–1440. 7 indexed citations

Mitri, Diletta Di, Arianna Calcinotto, Veronica Gil, et al.. (2017). Re-education of tumor-associated macrophages by CXCR2 blockade drives senescence enhancement and tumor inhibition in advanced prostate cancer. Annals of Oncology. 28. v272–v273. 1 indexed citations

Gil, Veronica, Govind Bhagat, Lydia Pleotis Howell, et al.. (2016). Deregulated expression of HDAC9 in B-cells promotes development of lymphoproliferative disease and lymphoma. Disease Models & Mechanisms. 9(12). 1483–1495. 39 indexed citations

10.

Ahmad, Zai, Veronica Gil, Louise Howell, et al.. (2015). Molecular and In Vivo Characterization of Cancer-Propagating Cells Derived from MYCN-Dependent Medulloblastoma. PLoS ONE. 10(3). e0119834–e0119834. 16 indexed citations

11.

Bansal, Nidhi, Kevin Petrie, Rossitza Christova, et al.. (2015). Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer. Oncotarget. 6(33). 34087–34105. 24 indexed citations

12.

Swords, Ronan, Tino Schenk, Sven Stengel, et al.. (2015). Inhibition of the PI3K/AKT/mTOR Pathway Leads to Down-Regulation of c-Myc and Overcomes Resistance to ATRA in Acute Myeloid Leukemia. Blood. 126(23). 1363–1363. 13 indexed citations

13.

Cubedo, Elena, Veronica Gil, Chae Hwa Kim, et al.. (2014). HDAC9 Expression Is Deregulated in Malignant B-Cell Lymphomas in Particular in Diffuse Large B Cell Lymphoma and Mantle Cell Lymphoma. Blood. 124(21). 5374–5374. 1 indexed citations

14.

Gil, Veronica, Louise Howell, Jenny Yeung, et al.. (2007). Ectopic Expression of HDAC9 in Murine Lymphoid System Leads to Altered Lymphocyte Numbers and Proliferation as Well as Predisposition to Tumorigenesis.. Blood. 110(11). 376–376. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact